| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 43.2742 | 19 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.1212 | 33 |
| GSM780709 | Untreated after 4 days (C3_1) | 41.7489 | 12 |
| GSM780719 | Untreated after 4 days (C1_2) | 41.7977 | 12 |
| GSM780720 | Untreated after 4 days (C2_2) | 44.1852 | 23 |
| GSM780721 | Untreated after 4 days (C3_2) | 40.3342 | 7 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 45.3295 | 29 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 46.0957 | 32 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 41.6449 | 12 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 46.3888 | 34 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 46.2889 | 33 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 51.0762 | 52 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 38.0549 | 3 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 43.0846 | 18 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 37.9356 | 2 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 45.0733 | 27 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 43.7309 | 21 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 43.3083 | 19 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 47.6583 | 40 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 44.4983 | 25 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 44.2893 | 24 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.0021 | 37 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 44.6558 | 25 |